Sophrosyne Capital’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Sophrosyne Capital’s Portfolio MNDT Stock Details MNDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-18,000	Closed	-$550K	–	56
2014 Q3	$550K	Buy	18,000 +10,900	+154%	+$361K	0.65%	36
2014 Q2	$289K	Sell	7,100 -2,900	-29%	-$113K	0.29%	45
2014 Q1	$618K	Sell	10,000 -23,700	-70%	-$1.68M	0.54%	38
2013 Q4	$1.47M	Buy	+33,700	New	+$1.32M	1.29%	24

Other funds holding MNDT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIM

SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

KDA

KPCB DGF Associates Menlo Park, California $58.3M AUM 27.35% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Sophrosyne Capital's MNDT Position: Q4 2014 in Review

Sophrosyne Capital sold out of Mandiant, Inc. Common Stock (MNDT) in Q4 2014, closing a stake of 18,000 shares — an estimated $550K sold.

Sophrosyne Capital first reported a position in MNDT in Q4 2013 and held it in 4 quarters. The position peaked at $1.47M in Q4 2013. 300 funds tracked by Wall St. Rank hold MNDT as of Q4 2014.

Sophrosyne Capital reported no remaining Mandiant, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
Sophrosyne Capital sold 18,000 Mandiant, Inc. Common Stock shares in Q4 2014, an estimated $550K.
Sophrosyne Capital first reported a position in Mandiant, Inc. Common Stock in Q4 2013 and held it in 4 quarters.
Sophrosyne Capital's Mandiant, Inc. Common Stock position peaked at $1.47M in Q4 2013.
300 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q4 2014.

Based on Sophrosyne Capital's 13F filing for Q4 2014, filed 26 Jan 2015.